Article
Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses
22 May 2024
Abstract excerpt
mRNA vaccines have emerged as an optimistic technological platform for vaccine innovation in this new scientific era. mRNA vaccines have dramatically altered the domain of vaccinology by offering a versatile and rapid approach to combating infectious diseases and virus-induced cancers. Clinical trials have demonstrated efficacy rates of 94-95% in preventing COVID-19, and mRNA vaccines have been increasingly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
